Skip to main content

Derrick W. Su, MD

Specialist

  • Medicare participating

At a glance

Years since graduation
15
In the NPI registry since
2011
Medicare patients seen, 2024
145

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2011Medical school: Boston University School of Medicine
  • 2011Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Specialist primary
    CA license A125217

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
145
Services billed
71,343
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, dexamethasone sodium phosphate, 1 mg1,02015
Injection, ondansetron hydrochloride, per 1 mg71212
Established patient office or other outpatient visit, 30-39 minutes293104
Administration of chemotherapy into vein, 1 hour or less16719
Established patient office or other outpatient visit, 40-54 minutes16361
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less12217
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes9536
Administration of additional new drug or substance into vein, 1 hour or less9114
Established patient office or other outpatient visit, 20-29 minutes2314
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1515

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Tagrisso (osimertinib mesylate)97
Eliquis (apixaban)
Other prescribers in Fountain Valley, CA
77
Hydroxyurea
Other prescribers in Fountain Valley, CA
72
Anastrozole
Other prescribers in Fountain Valley, CA
70
Procrit (epoetin alfa)47
Letrozole
Other prescribers in Fountain Valley, CA
41
Prednisone
Other prescribers in Fountain Valley, CA
39
Sodium Chloride (0.9 % sodium chloride)
Other prescribers in Fountain Valley, CA
36
Diphenhydramine Hcl36
Lenalidomide31

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 64 companies reported 390 payments worth $10,310 in total to this clinician.

By type
Food and Beverage$9,277
Long term medical supply or device loan$1,000
Education$32.72

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jan 23, 2025Novartis Pharmaceuticals Corporation
Jan 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Feb 21, 2025Novartis Pharmaceuticals Corporation
Feb 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Mar 26, 2025Novartis Pharmaceuticals Corporation
Mar 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
May 15, 2025Novartis Pharmaceuticals Corporation
May 15, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Apr 24, 2025Novartis Pharmaceuticals Corporation
Apr 24, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jun 12, 2025Novartis Pharmaceuticals Corporation
Jun 12, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jul 25, 2025Novartis Pharmaceuticals Corporation
Jul 25, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Aug 21, 2025Novartis Pharmaceuticals Corporation
Aug 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Oct 23, 2025Novartis Pharmaceuticals Corporation
Oct 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Nov 26, 2025Novartis Pharmaceuticals Corporation
Nov 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
All 13 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 30, 2025Novartis Pharmaceuticals Corporation
Dec 30, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Nov 26, 2025Novartis Pharmaceuticals Corporation
Nov 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Oct 23, 2025Novartis Pharmaceuticals Corporation
Oct 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Sep 25, 2025Amgen Inc.
Sep 25, 2025
Education
in-kind
$32.72
Sep 19, 2025Novartis Pharmaceuticals Corporation
Sep 19, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Aug 21, 2025Novartis Pharmaceuticals Corporation
Aug 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jul 25, 2025Novartis Pharmaceuticals Corporation
Jul 25, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jun 12, 2025Novartis Pharmaceuticals Corporation
Jun 12, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
May 15, 2025Novartis Pharmaceuticals Corporation
May 15, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Apr 24, 2025Novartis Pharmaceuticals Corporation
Apr 24, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Mar 26, 2025Novartis Pharmaceuticals Corporation
Mar 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Feb 21, 2025Novartis Pharmaceuticals Corporation
Feb 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jan 23, 2025Novartis Pharmaceuticals Corporation
Jan 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Other Specialist clinicians in Fountain Valley

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 15, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1740569789. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.